Parametric Portfolio Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.01B | Buy |
11,359,738
+422,206
| +4% | +$71.8M | 1.06% | 11 |
|
|
2021
Q4 | $1.87B | Buy |
10,937,532
+127,325
| +1% | +$20.8M | 0.96% | 11 |
|
|
2021
Q3 | $1.75B | Sell |
10,810,207
-223,610
| -2% | -$38.1M | 0.99% | 11 |
|
|
2021
Q2 | $1.82B | Buy |
11,033,817
+179,159
| +2% | +$29.7M | 1.02% | 8 |
|
|
2021
Q1 | $1.78B | Buy |
10,854,658
+354,559
| +3% | +$57.4M | 1.02% | 8 |
|
|
2020
Q4 | $1.65B | Buy |
10,500,099
+52,629
| +0.5% | +$7.77M | 1.03% | 7 |
|
|
2020
Q3 | $1.56B | Sell |
10,447,470
-153,850
| -1% | -$22.8M | 1.12% | 7 |
|
|
2020
Q2 | $1.49B | Buy |
10,601,320
+104,388
| +1% | +$15.2M | 1.14% | 7 |
|
|
2020
Q1 | $1.38B | Buy |
10,496,932
+524,650
| +5% | +$74.4M | 1.26% | 7 |
|
|
2019
Q4 | $1.45B | Buy |
9,972,282
+329,834
| +3% | +$44.7M | 1.06% | 8 |
|
|
2019
Q3 | $1.25B | Sell |
9,642,448
-324,951
| -3% | -$42.8M | 1.01% | 9 |
|
|
2019
Q2 | $1.39B | Buy |
9,967,399
+280,544
| +3% | +$38.8M | 1.15% | 7 |
|
|
2019
Q1 | $1.35B | Buy |
9,686,855
+423,403
| +5% | +$56.7M | 1.17% | 6 |
|
|
2018
Q4 | $1.2B | Buy |
9,263,452
+250,154
| +3% | +$34.9M | 1.19% | 6 |
|
|
2018
Q3 | $1.25B | Buy |
9,013,298
+389,859
| +5% | +$51.8M | 1.09% | 6 |
|
|
2018
Q2 | $1.05B | Buy |
8,623,439
+61,570
| +0.7% | +$7.68M | 0.99% | 8 |
|
|
2018
Q1 | $1.1B | Buy |
8,561,869
+245,864
| +3% | +$33.2M | 1.08% | 7 |
|
|
2017
Q4 | $1.16B | Buy |
8,316,005
+289,353
| +4% | +$40.3M | 1.16% | 6 |
|
|
2017
Q3 | $1.04B | Buy |
8,026,652
+253,568
| +3% | +$33.6M | 1.13% | 6 |
|
|
2017
Q2 | $1.03B | Buy |
7,773,084
+2,383,976
| +44% | +$304M | 1.23% | 5 |
|
|
2017
Q1 | $671M | Sell |
5,389,108
-1,726,730
| -24% | -$206M | 1.03% | 6 |
|
|
2016
Q4 | $820M | Buy |
7,115,838
+701,196
| +11% | +$81M | 1.14% | 5 |
|
|
2016
Q3 | $758M | Buy |
6,414,642
+148,335
| +2% | +$18M | 1.14% | 5 |
|
|
2016
Q2 | $760M | Buy |
6,266,307
+305,554
| +5% | +$34.7M | 1.2% | 5 |
|
|
2016
Q1 | $645M | Buy |
5,960,753
+200,125
| +3% | +$20.7M | 1.04% | 5 |
|
|
2015
Q4 | $592M | Buy |
5,760,628
+364,367
| +7% | +$36.6M | 1.01% | 6 |
|
|
2015
Q3 | $504M | Buy |
5,396,261
+813,313
| +18% | +$78.7M | 0.98% | 8 |
|
|
2015
Q2 | $447M | Buy |
4,582,948
+167,969
| +4% | +$16.8M | 0.87% | 8 |
|
|
2015
Q1 | $444M | Buy |
4,414,979
+84,212
| +2% | +$8.56M | 0.89% | 7 |
|
|
2014
Q4 | $453M | Sell |
4,330,767
-39,732
| -0.9% | -$4.19M | 0.95% | 6 |
|
|
2014
Q3 | $466M | Sell |
4,370,499
-7,385
| -0.2% | -$766K | 1.03% | 6 |
|
|
2014
Q2 | $458M | Sell |
4,377,884
-117,507
| -3% | -$11.9M | 1.03% | 7 |
|
|
2014
Q1 | $442M | Buy |
4,495,391
+85,275
| +2% | +$7.91M | 1.05% | 6 |
|
|
2013
Q4 | $404M | Buy |
4,410,116
+130,052
| +3% | +$12M | 0.98% | 7 |
|
|
2013
Q3 | $371M | Sell |
4,280,064
-28,221
| -0.7% | -$2.53M | 1.01% | 5 |
|
|
2013
Q2 | $370M | Buy |
+4,308,285
| New | +$366M | 1.08% | 5 |
|
Other funds holding JNJ
WA
Parametric Portfolio Associates's JNJ Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Johnson & Johnson (JNJ) stake by 3.9% in Q1 2022, buying an estimated $71.8M and bringing the position to 11,359,738 shares worth $2.01B. The position accounts for 1.06% of the portfolio, ranked #11.
Parametric Portfolio Associates first reported a position in JNJ in Q2 2013 and has held it in 36 quarters since. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.
- Parametric Portfolio Associates held 11,359,738 shares of Johnson & Johnson worth $2.01B as of Q1 2022.
- Parametric Portfolio Associates bought 422,206 Johnson & Johnson shares in Q1 2022, an estimated $71.8M.
- Johnson & Johnson made up 1.06% of Parametric Portfolio Associates's portfolio in Q1 2022, its #11 holding.
- Parametric Portfolio Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 36 quarters since.
- 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.